Due to the risk of teratogen effects of many antihypertensive drugs (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers), the therapeutic options for hypertension management are restricted and more challenging 2. This evidence concerns the gene ACE and Hypertension.